THE BIG PITCH 14 | Bernadette Porter Honorary Consultant Nurse and Founder and CEO of NeuroResponse® Bernadette is a Clinical Entrepreneur and an alumnus of the NHS Innovation Accelerator Programme. She is the Founder and CEO of NeuroResponse® – a digital care model co-designed with people living with Multiple Sclerosis (MS) to detect and treat urinary tract infections quickly avoiding deterioration and presentation at Emergency Departments. Bernadette has had a long career in neurology nursing and is an Honorary Consultant Nurse in Multiple Sclerosis at The National Hospital for Neurology and Neurosurgery, UCLH NHS Foundation Trust and The Royal Free Foundation Trust. Bernadette has a track record of successfully and collaboratively challenging multidisciplinary teams to deliver patient focused care. Bernadette has received many awards including an MBE for services to nursing. Under Bernadette’s leadership, NeuroResponse® evolved from a proof of concept to a commissioned service and was awarded SBRI Phase 1 and Phase 2 funding to improve the MS service and scale to people and families living with Dementia and Parkinson’s disease. Bernadette believes the support and mentorship offered on the NHS Innovation Accelerator and Clinical Entrepreneur Programme have been key in building confidence and success to date. www.neuroresponse.com Email: [email protected] YouTube: NeuroResponse Debbie Wake CEO and Co-Founder of MyWay Digital Health (MWDH) MWDH is a University of Dundee spin out company (inc. 2017). Debbie is also a Diabetes Consultant, and Clinical Reader at University of Edinburgh and (MBChB, BSc, PhD, Clin Ed Dip), a Diabetes UK Clinical Champion, a 2017/18 NHS Innovation Accelerator Fellow and one of nine 2019 IUK Women in Innovation Award winners. MWDH’s vision is to improve the lives of people with diabetes (and other long-term conditions) globally through affordable data-driven solutions. Their flagship product; MyWay Diabetes (MWD)), is multi-award winning, improves health outcomes and saves costs (5:1 ROI). MWD has been deployed in~ 30% of NHS territories. MWDH have an office in Dubai and are now delivering in Middle East and Malaysia. MWDH is at the forefront of diabetes artificial intelligence/ machine learning work (supported through IUK Digital Health Catalyst and AI awards) leading to emerging products delivering clinician decision support, population analytics, risk prediction and precision medicine. Debbie also leads international diabetes education programmes, and was previously a health columnist for a national UK newspaper and TV doctor/ presenter for STVs ‘The Hour’ programme. www.mwdh.co.uk Email: [email protected] Twitter: @docdebbie LinkedIn:debbie-wake-64335923/ The CEP is by far, the most important means by which hard working, committed NHS employees with ideas can add value to the constructive development of services for patients, staff and the organisation.
RkJQdWJsaXNoZXIy MTA4ODM=